# FDA Inspection 1164784 - Klatsky, Peter Charles, MD, Inc - March 09, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/klatsky-peter-charles-md-inc/8f14e1ba-c777-4074-95ca-29e45ce59b05
Source feed: FDA_Inspections

> FDA Inspection 1164784 for Klatsky, Peter Charles, MD, Inc on March 09, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164784
- Company Name: Klatsky, Peter Charles, MD, Inc
- Inspection Date: 2022-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279700 - 2025-07-24](https://www.globalkeysolutions.net/records/fda_inspections/klatsky-peter-charles-md-inc/dabded09-7b16-440f-ac76-4035364eccb0)
- [FDA Inspection 1279700 - 2025-07-24](https://www.globalkeysolutions.net/records/fda_inspections/klatsky-peter-charles-md-inc/94702a81-71a4-4177-9e6c-2013294857b5)
- [FDA Inspection 1164784 - 2022-03-09](https://www.globalkeysolutions.net/records/fda_inspections/klatsky-peter-charles-md-inc/ea5d1d86-270b-4c8e-8749-63c99b8d7ff4)

Company: https://www.globalkeysolutions.net/companies/klatsky-peter-charles-md-inc/c9172d79-c9d1-4ffa-a3b7-61c618f8d9e9

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d